NHP.V · Lumiera Health Inc

-

Please sign in to comment on NHP.V

1 Comment

Admin

4 years, 1 month ago

Lumiera Health Inc is currently in a long term downtrend where the price is trading 38.2% below its 200 day moving average.

From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.

Lumiera Health Inc's total revenue rose by 13.1% to $145K since the same quarter in the previous year.

Its net income has dropped by 66.6% to $-1M since the same quarter in the previous year.

Finally, its free cash flow fell by 40.5% to $-200K since the same quarter in the previous year.

Based on the above factors, Lumiera Health Inc gets an overall score of 2/5.

ISIN	CA5502541066
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
Exchange	V
CurrencyCode	CAD

Market Cap	850K
PE Ratio	None
Target Price	None
Dividend Yield	0.0%
Beta	1.97

ABOUT

Lumiera Health Inc

Lumiera Health Inc., together with its subsidiaries, develops and commercializes evidence-based botanical products for the healthcare in Canada. It sells oral and topical botanical agents to manage unmet medical needs; and solutions for sleep-aids and pain management. The company offers herbal tonics and supplements for cardiovascular health, stress relief, bones, joints and muscle mobility, and energy and immunity under the Holizen brand; sleep aid products under the Bazzzics brand; and pain relief cream under the Awaye brand. Lumiera Health Inc. is headquartered in Saint-Hubert, Canada.

NHP.V · Lumiera Health Inc

-

Lumiera Health Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Lumiera Health Inc using a moving average strategy